BRIEF published on 01/20/2025 at 18:05, 1 year 7 months ago Capital changes at DMS Group following the acquisition of SFT Acquisition Capital Increase Verso Capital DMS SFT
BRIEF published on 01/17/2025 at 08:05, 1 year 8 months ago DMS Group: Status of voting rights and shares as of December 31, 2024 Voting Rights Actions Euronext Growth Medical Imaging DMS Group
BRIEF published on 01/16/2025 at 17:50, 1 year 8 months ago Dynamic growth for DMS Group in 2024 Innovation International Growth Medical Imaging Radiology
PRESS RELEASE published on 01/16/2025 at 17:45, 1 year 8 months ago DMS GROUP: ANOTHER YEAR OF DYNAMIC GROWTH Diagnostic Medical Systems (DMS) reports €46.1M revenue in 2024, 9% growth vs 2023. Focus on Imaging 2027 strategy driving expansion of product range & solutions Revenue Growth Medical Imaging Product Development DMS Group Imaging 2027
BRIEF published on 01/14/2025 at 11:05, 1 year 8 months ago DMS Group: Videoconference for Investors on January 16, 2025 Financial Results Investors Registration DMS Group Videoconference
BRIEF published on 01/08/2025 at 11:05, 1 year 8 months ago DMS Group organizes a videoconference for its shareholders Shareholders Investors Turnover DMS Group Videoconference
BRIEF published on 12/20/2024 at 18:05, 1 year 8 months ago Verso Capital strengthens its presence in DMS Group Medical Imaging Merger And Acquisition Development Strategy DMS Group Verso Capital
PRESS RELEASE published on 12/20/2024 at 18:00, 1 year 8 months ago Verso Capital increases its Stake in DMS Group Diagnostic Medical Systems Group announces Verso Capital's increased stake and strategic advancements. Achievements include partnerships and contract nearing finalization for mobile x-ray units Partnerships Diagnostic Medical Systems Group Verso Capital Strategic Advancements Mobile X-ray Units
BRIEF published on 10/17/2024 at 18:05, 1 year 11 months ago Diagnostic Medical Systems: revenue growth in the 3rd quarter of 2024 Innovation International Growth Turnover Radiology
BRIEF published on 10/08/2024 at 18:05, 1 year 11 months ago Diagnostic Medical Systems: Videoconference for investors and shareholders Financial Results Development Strategy Diagnostic Medical Systems Videoconference 2024 Investors And Shareholders
Published on 09/18/2026 at 00:25, 23 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 2 hours 33 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 2 hours 33 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 2 hours 43 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 15:55, 8 hours 53 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 19:00, 5 hours 48 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 5 hours 50 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 6 hours 23 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 6 hours 38 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 7 hours 2 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 7 hours 8 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 7 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 17 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
